Cargando…
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
BACKGROUND: A decade ago, statin persistence was < 50% after 1 year, and recent short-term analyses have revealed very little progress in improving statin persistence, even in patients with a prior cardiovascular (CV) event. Data on longer-term statin persistence are lacking. We measured long-ter...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747753/ https://www.ncbi.nlm.nih.gov/pubmed/31526399 http://dx.doi.org/10.1186/s12944-019-1099-z |